What should you know about skin booster melasma?

Melasma is a pigment condition that often appears as irregular brown or grey-brown patches, commonly on the face. Injection points, inflammation, heat, or strong aftercare products may make uneven colour more noticeable in some people. A skin booster is designed to place a hydrating product within the skin, rather than target excess pigment. That distinction matters: smoother-feeling skin does not necessarily mean the patches have faded. Review whether the marks are active, recently changing, or accompanied by irritation before choosing an injectable approach.

Have a qualified clinician examine the pigment and discuss your previous reactions, pregnancy plans, medicines, and current products. Use gentle cleansing and consistent broad-spectrum sun protection, because light exposure can encourage melasma to persist. Do not combine a new injectable with several exfoliating or brightening products at once. Depending on the pattern and skin sensitivity, a clinician may discuss pigment care or options such as Chemical Peel, Microneedling, Skin Brightening Treatment, or Laser Toning. More background is available under Melasma, Dark Patches On Skin, and Uneven Skin Tone.

Arrange a review if a patch changes quickly, bleeds, crusts, becomes painful, or looks unlike your other marks; those features need diagnosis rather than cosmetic treatment. After injections, seek prompt medical advice for spreading redness, increasing warmth, severe pain, pus, marked swelling, fever, or any new vision symptom. Sudden swelling of the lips or face or trouble breathing requires emergency help. Sun-Damaged Skin can also contribute to uneven tone, so mention your sun exposure history during assessment.

Ask whether the pigment is consistent with melasma, whether a skin booster could aggravate it, which product and injection depth are planned, and how to protect the area while it settles. Ask which symptoms should prompt an urgent call and when pigment-focused treatment can safely be considered.